These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 9873477

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Development of a new class of nonimidazole histamine H(3) receptor ligands with combined inhibitory histamine N-methyltransferase activity.
    Apelt J, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H.
    J Med Chem; 2002 Feb 28; 45(5):1128-41. PubMed ID: 11855993
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Search for novel leads for histamine H3-receptor antagonists: amine derivatives.
    Stark H, Ligneau X, Lipp R, Arrang JM, Schwartz JC, Schunack W.
    Pharmazie; 1997 Jun 28; 52(6):419-23. PubMed ID: 9260265
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Design, synthesis, and structure-activity relationships of novel non-imidazole histamine H(3) receptor antagonists.
    Linney ID, Buck IM, Harper EA, Kalindjian SB, Pether MJ, Shankley NP, Watt GF, Wright PT.
    J Med Chem; 2000 Jun 15; 43(12):2362-70. PubMed ID: 10882362
    [Abstract] [Full Text] [Related]

  • 28. Pharmacological characterization of H3 receptor antagonists with imidazole, thioimidazole and thioimidazoline polar groups in the side chain.
    Barocelli E, Ballabeni V, Chiavarini M, Bertoni S, Mor M, Plazzi PV, Bordi F, Impicciatore M.
    Inflamm Res; 2000 Apr 15; 49 Suppl 1():S62-3. PubMed ID: 10864424
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties.
    Esbenshade TA, Fox GB, Krueger KM, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan L, Wetter J, Marsh K, Bennani YL, Cowart MD, Sullivan JP, Hancock AA.
    J Pharmacol Exp Ther; 2005 Apr 15; 313(1):165-75. PubMed ID: 15608078
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Benzophenone derivatives and related compounds as potent histamine H3-receptor antagonists and potential PET/SPECT ligands.
    Sasse A, Ligneau X, Sadek B, Elz S, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H.
    Arch Pharm (Weinheim); 2001 Feb 15; 334(2):45-52. PubMed ID: 11268774
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Non-imidazole histamine H3 ligands. Part I. Synthesis of 2-(1-piperazinyl)- and 2-(hexahydro-1H-1,4-diazepin-1-yl)benzothiazole derivatives as H3-antagonists with H1 blocking activities.
    Walczyński K, Guryn R, Zuiderveld OP, Timmerman H.
    Farmaco; 1999 Oct 30; 54(10):684-94. PubMed ID: 10575738
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Development of a pharmacophore model for histamine H3 receptor antagonists, using the newly developed molecular modeling program SLATE.
    De Esch IJ, Mills JE, Perkins TD, Romeo G, Hoffmann M, Wieland K, Leurs R, Menge WM, Nederkoorn PH, Dean PM, Timmerman H.
    J Med Chem; 2001 May 24; 44(11):1666-74. PubMed ID: 11356102
    [Abstract] [Full Text] [Related]

  • 39. Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: Preliminary pharmacological investigation.
    Barocelli E, Ballabeni V, Manenti V, Flammini L, Bertoni S, Morini G, Comini M, Impicciatore M.
    Pharmacol Res; 2006 Mar 24; 53(3):226-32. PubMed ID: 16364652
    [Abstract] [Full Text] [Related]

  • 40. Non-imidazole histamine NO-donor H3-antagonists.
    Tosco P, Bertinaria M, Di Stilo A, Cena C, Fruttero R, Gasco A.
    Farmaco; 2005 Mar 24; 60(6-7):507-12. PubMed ID: 15927183
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.